Drug intelligence / Profile preview

sodium sulfate + potassium sulfate + magnesium sulfate (Shandong Chengchuang Pharmaceutical Technology Development)

Development stage
Unknown
Lead developer
Shandong Chengchuang Pharmaceutical Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

LLN is an oral sulfate solution (OSS) developed by Shandong Chengchuang Pharmaceutical Technology Development for bowel preparation prior to colonoscopy. It is a combination of sodium sulfate, potassium sulfate, and magnesium sulfate. As an osmotic laxative, it works by drawing and retaining water in the intestinal lumen, thereby increasing intraluminal pressure and stimulating peristalsis to clear the bowel. In clinical trials, LLN oral solution has been evaluated for its efficacy and safety compared to standard polyethylene glycol (PEG) electrolyte solutions, often demonstrating non-inferiority in bowel cleansing quality with a potentially lower volume requirement. It was approved by the NMPA in China in 2021 for bowel cleansing in adults.

Other names
compound sodium sulfate oral solutionoral sulfate solutionOSSLLN oral solution

Beyond the preview

Go deeper on sodium sulfate + potassium sulfate + magnesium sulfate (Shandong Chengchuang Pharmaceutical Technology Development).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium sulfate + potassium sulfate + magnesium sulfate (Shandong Chengchuang Pharmaceutical Technology Development).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call